Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    4 days ago
    Change Detected
    Summary
    New entries for Contacts/Locations and Study Status were added to the record history, with the latest version count updated to 37. An earlier version dated 2026-02-09 was removed from the history.
    Difference
    0.3%
    Check dated 2026-05-11T05:33:43.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, indicating a software or interface update rather than a modification to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:12:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history list.
    Difference
    0.1%
    Check dated 2026-04-18T13:19:26.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The record history now includes more version entries, with additions and deletions color-coded to show edits to Study Status and Contacts/Locations.
    Difference
    0.1%
    Check dated 2026-03-27T21:48:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and Revision v3.4.3 was removed from the history list.
    Difference
    0.1%
    Check dated 2026-03-20T17:09:18.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The history now includes revision v3.4.3 and excludes v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T15:18:30.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.